Chronic beta blocker use better than acute for peri-operative outcomes

In this single center study of patients undergoing non-cardiac surgery, those that were chronically on beta blockers were 2.7 times less likely to have a bad outcome (eg MI, cardiac arrest, or death) compared to those who were started on a beta blocker in the peri-operative period (after adjusting propensity scores). This adds weight to the value of seeing patients in preoperative clinics far before surgery (when feasible) to assess who does and does not need to be on a beta blocker (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment